SUNNYVALE, Calif., May 13, 2015 /PRNewswire/ -- Ce
Post# of 9122
Posted On: 05/13/2015 12:33:24 PM
SUNNYVALE, Calif., May 13, 2015 /PRNewswire/ -- Cepheid (CPHD) today announced that the World Health Organization (WHO) has assessed and listed Xpert® Ebola as eligible for procurement to Ebola affected countries. The program details can be found at: http://www.who.int/medicines/ebola-treatment/...proval/en/. Xpert Ebola is a molecular diagnostic test for Ebola Zaire Virus that delivers results in less than two hours. The test runs on the Cepheid GeneXpert® Systems, the world's leading molecular diagnostic platform with over 8,000 systems deployed globally in both developed and emerging market countries.
Actually, it did not take a great deal of time for this outfit to come up with an Ebola assay, get FDA emergency use authorization and now the above with WHO
Actually, it did not take a great deal of time for this outfit to come up with an Ebola assay, get FDA emergency use authorization and now the above with WHO
(0)
(0)Nanologix Inc (NNLX) Stock Research Links
Scroll down for more posts ▼